Sonnet Biotherapeutics Holdings Inc. Stock
Currently there is a rather positive sentiment for Sonnet Biotherapeutics Holdings Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 18 € there is potential for a 9682.61% increase which would mean more than doubling the current price of 0.18 € for Sonnet Biotherapeutics Holdings Inc..
Our community identified positive and negative aspects for Sonnet Biotherapeutics Holdings Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Sonnet Biotherapeutics Holdings Inc. stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.
Pros and Cons of Sonnet Biotherapeutics Holdings Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sonnet Biotherapeutics Holdings Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sonnet Biotherapeutics Holdings Inc. | - | - | - | - | - | - | - |
| Skylark Co Ltd | -3.800% | -6.349% | 11.321% | 18.000% | 22.069% | 62.385% | 38.281% |
| J D Wetherspoon plc | 1.270% | 0.629% | 12.676% | 11.111% | 15.108% | 65.975% | -30.736% |
| SSP Group plc | - | 8.671% | 23.684% | -15.315% | -5.051% | -27.132% | -45.349% |
Comments
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Show more
Ratings data for SONN provided by MarketBeat
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Show more
Ratings data for SONN provided by MarketBeat
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its price target lowered by analysts at Chardan Capital from $30.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for SONN provided by MarketBeat